Nearly 40,000 eye drops recalled nationwide over possible contamination

Nearly 40,000 eye drops recalled nationwide over possible contamination

Published August 21, 2026 4:11pm EDT Product was distributed by Medtech Products Inc. Nearly 40,000 bottles of eye drops are being recalled nationwide due to potential contamination, according to the Food and Drug Administration. Tarrytown, New York-based Prestige Brand Holdings is voluntarily recalling 39,060 bottles of its Clear Eyes Maximum Itchy Eye Relief eye drops due to a "lack of assurance of sterility," according to an FDA enforcement report.The affected product comes in 15-milliliter bottles with the lot code 2552A and an expiration date of Sep. 30, 2027. They were distributed by Medtech Products Inc., a Prestige Consumer Healthcare company. NEARLY 12 MILLION BOTTLES OF ROHTO EYE DROPS RECALLED OVER STERILITY CONCERNS, FDA ANNOUNCES Nearly 40,000 bottles of eye drops are being recalled nationwide due to potential contamination. (Getty Images)The FDA classified the recall as a Class II recall, which it describes as a "situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote."MILLIONS OF PRESCRIPTION EYE DROPS RECALLED NATIONWIDE OVER CONTAMINATION CONCERNSTicker Security Last Change Change % PBH PRESTIGE CONSUMER HEALTHCARE INC. 50.52 -1.16 -2.24% Other brands in the Prestige portfolio include Dramamine, Luden’s and Anacin. The FDA classified the recall as a Class II recall. (Getty Images)The company completed the acquisition of the Breathe Right brand – known for its nasal strips – and other assets from Foundation Consumer ​Healthcare in June in a deal valued at about $1.05 billion.CLICK HERE TO GET FOX BUSINESS ON THE GOFOX Business reached out to Prestige Brands for comment.

Original Source

Read the full article at Foxbusiness →

KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.